Ranking & Milestones

• SPL jumps up to number 383 in BS 1000 Giants !
  
  Surya Pharmaceutical Limited (SPL), is now ranked 383 in the prestigious Business Standard 1000 Giants list for 2010. In 2009, the Company was ranked 500 in the BS list whereas in the year 2010, it jumped up to capture rank 383 by registering a rapid growth. The BS 1000 list is compiled on the basis of Net Sales of a company during the mentioned fiscal year. SPL registered Net Sales of Rs 1134.13 crores in 2010 thereby posting an increase of 56.9% in its sales.The BS Industry Wise Performance SPL has ranked 331 in the Pharmaceuticals sector based on Standalone Net sales for fiscal year 2010!
• SHL acquires Medimart
  
  VIVA, the Pharmacy Retail Brand of Surya Healthcare Ltd. has added 47 more pharmacy stores to its kitty. The Company has acquired one of the leading pharmacy retail chains of South India-Medimart.The acquisition brings along with it 47 Medimart stores located all over the state of Andhra Pradesh.
• SPL enters global database of Dun & Bradstreet
  
  D&B (NYSE:DNB) is the world's leading source of commercial information and insight on businesses, enabling companies to Decide with Confidence for last169 years.
  
  D&B manages the world's most valuable commercial database with information on 100 million companies. Business information is gathered in over 200 countries, in 82 languages or dialects, covering 181 monetary currencies. The database is refreshed over 1.5 million times a day as part of commitment to provide accurate, comprehensive information to its customers globally. D&B global database helps turn information into insight to develop conclusive, fact-based strategies that helps in gaining a competitive edge and transforming enterprise into a nimble, customer-focused, more profitable business. As the leading provider of business information for credit, marketing and purchasing decisions worldwide, D&B can help Surya in performing a wide range of business analyses.
• The prestigious Inc Magazine has ranked Surya Pharmaceutical Limited at the 77th rank among the top 500 best performing enterprises in India. The experts at the magazine followed a weighted analysis of several parameters, annualized for comparison. These included- Revenue Growth, Net Income Growth, Profitability and returns to evaluate performance. The ranking model takes into account net sales, operating profits and profit after tax.
• Economic Times, the foremost business daily of India has ranked Surya Pharmaceutical Limited as one among top ET 500 companies. Per the ranking Surya has entered the top league in the Indian Industry scene. According to the latest survey published by Economic Times, Surya has ranked 417th out of the top ET 500 companies. ET 500 is all about India Inc's biggest and the best, and the passion to grow and excel has put the Company in a different league. Surya is in this list ,as its growth over the past three years has been dramatic, both through the organic and inorganic route, which prompted ET to highlight this feat. The survey calculated the cummulative annualised growth rate (CAGR) over the last three years for all ET 500 companies at the level of revenues, PBDIT and net profit. The weighted average of these growth rates was considered for ranking the companies.
• Business Standard, a name to reckon with, amongst the reputed financial papers of the country credits Surya's phenomenal growth. It says- "Surya Pharmaceutical Limited, with a turnover of Rs 1,130 crores, has emerged as one of the fastest growing, listed companies in the country. Powered by acquisitions, Surya, started by first generation entrepreneur Rajiv Goyal in 1992, has clocked 30-40 per cent growth annually. Earlier this year, the firm ventured into the lucrative domestic formulation business to become an integrated player instead of remaining a bulk supplier and a contract manufacturer."

• Franchise Mart, a reputed e zine highlights that the partnership between Surya and medical footwear giant Crocs will revolutionarise medical footwear in india and other neighbouring countries. Quoting Ms. Megan Welch, Crocs' Senior Manager for Product Management , Franchise Mart writes, "We now have a great platform to retail our products in India with Surya Pharmaceuticals, which offers several health and pharma products that are of the same category. Crocs Rx Medical offers a wide range of footcare products like shoes and socks which are specially designed for specific medical and therapeutic applications. The best part is that these footwear products are enhanced with the nano-silver technology and are made with Croslitetm Ag+ material. We are extremely excited about this collaboration and are looking forward to raising our profile further with this venture."

SPL ranks 398 in the prestigious FORTUNE India 500 list & Ranked no: 20 in Indian Pharmaceutical Sector

SPL has ranked 398 in the prestigious FORTUNE India 500 list! The Fortune India 500 list features India`s LARGEST CORPORATIONS!

Not only that, it outranked Pharmaceutical giants like Aventis Pharma, Alembic, Arch Pharmalabs and Ankur Drugs to climb to number 20 in the top Drugs & Pharmaceuticals companies of India!

Companies in the Fortune 500 list are ranked on the parameters of both Revenue & Income, they are ranked by their latest annual audited total income for the financial year ending on or before June 30, 2010. The Total Income includes Core Operating Income ( Net sales) plus other Extraordinary Income. Audited results declared before October 31st, 2010 have been used for the calculations. The numbers have been sourced from two corporate databases- the Centre for Monitoring of Indian Economies Prowess and Capitaline Plus by Capital Market Publishers India.